Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma

Detalles Bibliográficos
Autores principales: Yan, Junya, Deng, Long, Yu, Jiayi, Wu, Xiaowen, Wang, Shaoyu, Cang, Shundong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Letter to the Journal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660794/
https://www.ncbi.nlm.nih.gov/pubmed/37987157
http://dx.doi.org/10.1002/ctm2.1478
_version_ 1785148429557563392
author Yan, Junya
Deng, Long
Yu, Jiayi
Wu, Xiaowen
Wang, Shaoyu
Cang, Shundong
author_facet Yan, Junya
Deng, Long
Yu, Jiayi
Wu, Xiaowen
Wang, Shaoyu
Cang, Shundong
author_sort Yan, Junya
collection PubMed
description
format Online
Article
Text
id pubmed-10660794
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-106607942023-11-21 Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma Yan, Junya Deng, Long Yu, Jiayi Wu, Xiaowen Wang, Shaoyu Cang, Shundong Clin Transl Med Letter to the Journal John Wiley and Sons Inc. 2023-11-21 /pmc/articles/PMC10660794/ /pubmed/37987157 http://dx.doi.org/10.1002/ctm2.1478 Text en © 2023 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Journal
Yan, Junya
Deng, Long
Yu, Jiayi
Wu, Xiaowen
Wang, Shaoyu
Cang, Shundong
Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma
title Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma
title_full Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma
title_fullStr Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma
title_full_unstemmed Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma
title_short Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma
title_sort multi‐cohort analysis identifies somatic ntrk mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma
topic Letter to the Journal
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660794/
https://www.ncbi.nlm.nih.gov/pubmed/37987157
http://dx.doi.org/10.1002/ctm2.1478
work_keys_str_mv AT yanjunya multicohortanalysisidentifiessomaticntrkmutationsasabiomarkerforimmunecheckpointinhibitoruseincutaneousmelanoma
AT denglong multicohortanalysisidentifiessomaticntrkmutationsasabiomarkerforimmunecheckpointinhibitoruseincutaneousmelanoma
AT yujiayi multicohortanalysisidentifiessomaticntrkmutationsasabiomarkerforimmunecheckpointinhibitoruseincutaneousmelanoma
AT wuxiaowen multicohortanalysisidentifiessomaticntrkmutationsasabiomarkerforimmunecheckpointinhibitoruseincutaneousmelanoma
AT wangshaoyu multicohortanalysisidentifiessomaticntrkmutationsasabiomarkerforimmunecheckpointinhibitoruseincutaneousmelanoma
AT cangshundong multicohortanalysisidentifiessomaticntrkmutationsasabiomarkerforimmunecheckpointinhibitoruseincutaneousmelanoma

Ejemplares similares